Charles Schwab’s Beta Bionics BBNX Stock Holding History
Bought
Maintained
Sold
Other funds holding BBNX
Charles Schwab's BBNX Position: Q3 2026 in Review
Charles Schwab increased its Beta Bionics (BBNX) stake by 13% in Q3 2026, buying an estimated $796K and bringing the position to 395,182 shares worth $7.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2315.
Charles Schwab first reported a position in BBNX in Q1 2025 and has held it in 7 quarters since. The position peaked at $10.1M in Q4 2025. 153 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.
- Charles Schwab held 395,182 shares of Beta Bionics worth $7.5M as of Q3 2026.
- Charles Schwab bought 44,309 Beta Bionics shares in Q3 2026, an estimated $796K.
- Beta Bionics made up ﹤0.01% of Charles Schwab's portfolio in Q3 2026, its #2315 holding.
- Charles Schwab first reported a position in Beta Bionics in Q1 2025 and has held it in 7 quarters since.
- Charles Schwab's Beta Bionics position peaked at $10.1M in Q4 2025.
- 153 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.
Based on Charles Schwab's 13F filing for Q3 2026, filed 16 Nov 2026.